Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir plus probenecid for hospitalized patients with mpox or smallpox
jRCTs031230652Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cidofovir and probenecid in mpox and smallpox, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Skin lesion PCR viral clearance at day 14. Started Feb 2024; status: completed.
02
Drugs
cidofovirprobenecid
03
Conditions
mpoxsmallpox
Beyond the preview
Go deeper on jRCTs031230652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230652.